| Literature DB >> 23793695 |
Caryl M Beynon1, Amy Luxton, Rhiannon Whitaker, N Tim Cable, Lucy Frith, Adrian H Taylor, Lu Zou, Peter Angell, Scott Robinson, Dave Holland, Sharon Holland, Mark Gabbay.
Abstract
OBJECTIVES: To test whether older drug users (aged 40 and over) could be recruited to an exercise referral (ER) scheme, to evaluate the feasibility and acceptability and measure the impact of participation on health.Entities:
Keywords: Health services administration & management; Mental health; Public health
Year: 2013 PMID: 23793695 PMCID: PMC3664354 DOI: 10.1136/bmjopen-2013-002619
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Summary of participants' baseline characteristics
| Males N=12 | Females N=5 | Total N=17 | ||||
|---|---|---|---|---|---|---|
| Variables | Mean (SD) | Range | Mean (SD) | Range | Mean (SD) | Range |
| Age | 47.3 (6.8) | 40.5–60.7 | 43.4 (1.6) | 41.6–45.4 | 46.1 (6.0) | 40.5–60.7 |
| Height | 174.2 (5.4) | 167–186 | 163.1 (6.9) | 156–174.5 | 171 (7.7) | 156–186 |
| BMI | 26.7 (5.8) | 18.8–36.0 | 25.5 (5.1) | 19.7–31.6 | 26.3 (5.4) | 18.8–36.0 |
| Weight | 80.7 (16.2) | 56.5–106.4 | 67.3 (10.9) | 52.7–80.9 | 76.8 (15.8) | 52.7–106.4 |
| Exercise a week before baseline (min) | 177.7 (147.3) | 0–480 | 328 (315.2) | 80–840 | 221.9 (211.5) | 0–840 |
| SBP | 144.3 (17.4) | 118–172 | 132.4 (26.8) | 108–173 | 140.8 (20.5) | 108–173 |
| DBP | 82.7 (8.4) | 71–97 | 81.6 (14.3) | 67–101 | 82.4 (10.0) | 67–101 |
| MAP | 103.2 (8.5) | 88.7–117.3 | 98.6 (15.7) | 80.7–116.0 | 101.9 (10.8) | 80.7–117.3 |
| Rest heart rate | 80.6 (10.2) | 61–95 | 86.4 (9.9) | 71–98 | 82.3 (10.2) | 61–98 |
| METs | 12.0 (3.1) | 5.3–15.6 | 11.6 (3.1) | 8.9–15.6 | 11.9 (3.0) | 5.3–15.6 |
| EQ-5D-3L index | 0.83 (0.2) | 0.52–1 | 0.68 (0.2) | 0.26–0.85 | 0.8 (0.2) | 0.26–1 |
| EQ-5D-3L VAS | 65.2 (24.8) | 30–100 | 43.2 (26.9) | 5–80 | 58.1 (26.7) | 5–100 |
BMI, body mass index; DBP, diastolic blood pressure; EQ-5D-3L index and EQ-5D-3L VAS, EQ-5D-3L quality of life index and visual analogue scale scores, respectively; MAP, mean arterial pressure; METs, metabolic equivalents; SBP, systolic blood pressure.
Figure 1Weeks attended and total number of attendances per participant.
Figure 2Participant flow diagram.
Differences between baseline and follow-up health measures
| Variables | Baseline mean (SD) | Postexercise mean (SD) | Difference* (95% CIs) | Paired t (significance) |
|---|---|---|---|---|
| SBP† | 136.6 (15.5) | 133.6 (13.3) | −3.0 (−14.6 to 8.6) | −0.61 (0.56) |
| DBP† | 83.6 (9.4) | 80.8 (7.4) | −2.9 (−7.2 to 1.4) | −1.59 (0.16) |
| MAP† | 101.3 (9.5) | 98.4 (6.8) | −2.9 (−7.4 to 1.5) | −1.56 (0.16) |
| Heart rate† | 85.8 (10.5) | 82.1 (14.9) | −3.6 (−13.9 to 6.7) | −0.83 (0.43) |
| METs† | 12.4 (2.4) | 12.5 (3.5) | 0.1 (−2.6 to 2.7) | 0.05 (0.96) |
| EQ-5D-3L index‡ | 0.8 (0.2) | 0.8 (0.2) | −0.0 (−0.1 to 0.0) | −0.65 (0.53) |
| EQ-5D-3L VAS‡ | 65.0 (25.2) | 73.8 (19.3) | 8.8 (−6.5 to 24.0) | 1.27 (0.23) |
*Negative indicates reduction in value at follow-up.
†N=8 pairs.
‡N=12 pairs.
DBP, diastolic blood pressure; EQ-5D-3L index and EQ-5D-3L VAS, EQ-5D-3L quality of life index and visual analogue scale scores, respectively; MAP, mean arterial pressure; METs, metabolic equivalents; SBP, systolic blood pressure.
ANCOVA test results of demographic covariates and attendance data on the changes of each of the health measures (p value) separately
| Variables | Age | Height | Weight | Exercise in past week | Number of attendances | Number of weeks completed |
|---|---|---|---|---|---|---|
| Systolic | 0.06 | 0.52 | 0.74 | 0.82 | 0.45 | 0.78 |
| Diastolic | 1.00 | 0.03* | 0.54 | 0.49 | 1 | 0.15 |
| Mean arterial pressure | 0.15 | 0.05* | 0.92 | 0.81 | 0.52 | 0.54 |
| Heart rate | 0.16 | 0.26 | 0.97 | 0.84 | 0.16 | 0.70 |
| METs | 0.07 | 1.00 | 0.04* | 0.76 | 0.07 | 0.03* |
| EQ-5D-3L index | 0.35 | 0.40 | 0.86 | 0.74 | 0.35 | 0.97 |
| EQ-5D-3L VAS | 0.40 | 0.25 | 0.49 | 0.53 | 0.40 | 0.96 |
*Significant at 5% level.
ANCOVA, analysis of covariance; MET, metabolic equivalent.